Ahmed M. Agiba

Researcher

Ahmed Agiba has worked for pharmaceutical companies in the Middle East, Africa, and worldwide.

He has published numerous international research/review articles in peer-review journals, international conference papers and theses.

Refine Search

Latest from Ahmed M. Agiba

Pharmaceutical

A close look at Oman’s pharmaceutical industry

Since the early 1980s, the Sultanate of Oman has been one of the first countries in the MENA region to establish “a state reserve stock” of essential medicines and medical supplies to deal with emergency situations, mitigate the effects of epidemics and disasters, and provide the necessary medical and emergency care at the proper time. 19 March 2024

Pharmaceutical

Disruption, uncertainty and Egyptian aid as war impacts pharma in the Middle East

The ongoing conflict involving Israelis and Palestinians represents a long-term threat to the peace and stability of the Middle East, but it is also impacting the production and flow of medicines and other medical supplies in the region, writes The Pharma Letter’s local correspondent. 23 November 2023

Pharmaceutical

Egypt and BRICS: a new force in the pharmaceutical sector?

Egypt is set to join BRICS next year as the bloc expands to include six new members. 6 September 2023

Pharmaceutical

Royal Vision 2030 to revitalize the pharmaceutical Industry in Saudi Arabia

In mid-2014, the Kingdom of Saudi Arabia (KSA) faced one of the most daunting economic development challenges of its modern history, when crude oil prices collapsed by more than half. 9 June 2023

Biotechnology

Gennecs: an Egyptian success story shaping biologics production at home and beyond

Research-based Egyptian pharma company Gennecs Pharmaceuticals, part of the Gennecs group, belongs to the to El Daba Holding Group, a trading conglomerate serving Egypt and the countries of the Gulf Cooperation Council that partners with local and international investors. 20 March 2023

Generics

Zeta Pharma's strategy in the Egyptian market: what was and what will be

Zeta Pharma is a fast-growing branded generic pharmaceutical company in the Egyptian market that was established in 2010 and started its production and marketing activities in 2015 on the hepatitis C virus products products Sofocivir, Zetaciver and Sofocivir Plus. 10 March 2023

Pharmaceutical

Report from Egypt's AmpleLogic Pharma Summit 2023

A report from the second edition of the AmpleLogic Pharma Summit, held last month at Hilton Cairo Heliopolis in Egypt. 2 March 2023

Pharmaceutical

UAE pharmaceutical market: where we are today

The United Arab Emirates (UAE) ranks first regionally in attracting multinational pharmaceutical companies. 13 January 2023

Pharmaceutical

Localization of pharmaceutical manufacturing in Egypt after the outbreak of COVID-19: Part Two

Since the outbreak of the COVID-19 pandemic, the Egyptian government has offered tremendous opportunities for the localization of the vaccine and biologics’ industry in Egypt, writes The Pharma Letter's local correspondent. 17 October 2022

Pharmaceutical

Localization of pharmaceutical manufacturing in Egypt after the outbreak of COVID-19: Part One

The outbreak of coronavirus disease (COVID-19) has brought the issue of localization to the forefront, which necessitated the need for localization of pharmaceutical manufacturing to achieve self-sufficiency and self-reliance, writes The Pharma Letter's local correspondent. 8 August 2022

Ahmed M. Agiba

Today's issue

Latest from Ahmed M. Agiba

Company Spotlight